Follow
Mohamed A Daw, MD, MPS, PhD, MRCpath(1A), FTCDI
Mohamed A Daw, MD, MPS, PhD, MRCpath(1A), FTCDI
Professor of Clinical Epidemiology, Acting Physician of Internal Medicine,Tripoli University
Verified email at uot.edu.ly - Homepage
Title
Cited by
Cited by
Year
Bacteriocins: nature, function and structure
MA Daw, FR Falkiner
Micron 27 (6), 467-479, 1996
2191996
Hepatitis C virus in Arab world: a state of concern
MA Daw, AA Dau
The Scientific World Journal 2012, 2012
1212012
Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
MA Daw, A El-Bouzedi, ...
BMC infectious diseases 14, 1-9, 2014
802014
Libyan armed conflict 2011: mortality, injury and population displacement
MA Daw, A El-Bouzedi, AA Dau
African Journal of Emergency Medicine 5 (3), 101-107, 2015
732015
Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk
MA Daw, MA Elkaber, AM Drah, MM Werfalli, AA Mihat, IM Siala
Saudi Med J 23 (11), 1356-1360, 2002
722002
the effect of omeprazole on Helicobacter pylori and associated gastritis
MA Daw, P Deegan, E Leen, C O'MORÁIN
Alimentary pharmacology & therapeutics 5 (4), 435-439, 1991
641991
Positive Helicobacter pylori serology in rosacea patients
FC Powell, MA Daw, C Duguid
Irish J Med Sci 161 (Suppl), 75, 1992
611992
Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer
H Xia, MA Daw, S Sant, S Beattie, CT Keane, CA O'Morain
European Journal of Gastroenterology and Hepatology 5, 141-141, 1993
601993
Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya
MA Daw, A Shabash, A El-Bouzedi, AA Dau, ...
PloS one 9 (6), e98793, 2014
542014
The impact of armed conflict on the epidemiological situation of COVID-19 in Libya, Syria and Yemen
MA Daw
Frontiers in public health 9, 667364, 2021
512021
Seroepidemiology of hepatitis B virus markers among hospital health care workers
MA Daw, IM Siala, MM Warfalli, MI Muftah
Analysis of certain potential risk factors. Saudi Med J 21 (12), 1157-1160, 2000
512000
Geographic integration of hepatitis C virus: a global threat
MA Daw, AA El-Bouzedi, MO Ahmed, AA Dau, MM Agnan, AM Drah
World journal of virology 5 (4), 170, 2016
502016
Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients
HA Elasifer, YM Agnnyia, BA Al-Alagi, MA Daw
Virology Journal 7, 1-7, 2010
462010
Trends and patterns of deaths, injuries and intentional disabilities within the Libyan armed conflict: 2012-2017
MA Daw, AH El-Bouzedi, AA Dau
PloS one 14 (5), e0216061, 2019
452019
Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients
HX Xia, MA Daw, S Beattie, CT Keane, CA O’Morain
Irish journal of medical science 162, 91-94, 1993
451993
Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey
AN Elzouki, MN Smeo, M Sammud, O Elahmer, M Daw, A Furarah, ...
EMHJ-Eastern Mediterranean Health Journal, 19 (7), 589-599, 2013, 2013
422013
Characterization of wound infections among patients injured during the 2011 Libyan conflict
AA Dau, S Tloba, MA Daw
EMHJ-Eastern Mediterranean Health Journal, 19 (4), 356-361, 2013, 2013
402013
Corona virus infection in Syria, Libya and Yemen; an alarming devastating threat
MA Daw
Travel Med Infect Dis 101652 (10.1016), 2020
382020
Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission
MA Daw, A El-Bouzedi, AA Dau
BMC Research Notes 8, 1-9, 2015
342015
Libyan medical education; time to move forward
MA Daw, EA Elkhammas
Libyan Journal of Medicine 3 (1), 1-3, 2008
312008
The system can't perform the operation now. Try again later.
Articles 1–20